跳至主要内容
临床试验/NCT05690451
NCT05690451已完成不适用

The Role of Non-contrast Abbreviated MRI for Secondary Surveillance of Hepatocellular Carcinoma After Curative Treatment: a Prospective Multicenter Study

Seoul National University Hospital3 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2021年12月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
210
试验地点
3
主要终点
Accuracy per patient

研究概览

简要总结

This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.

详细描述

This study was designed as a prospective single-arm intra-individual comparison multicenter study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 20-year old and 85-year old
  • Patients with a history of curative treatment for HCC including surgical resection or local ablation
  • No recurrence after curative treatment of HCC for more than two years
  • Patient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)

排除标准

  • Estimated GFR less than 60
  • Previous history of severe allergic reaction to the iodinated contrast agent
  • Patients with claustrophobia who can't undergo MR examination
  • Patients having cochlear implants or cardiac pacemaker

结局指标

主要结局

Accuracy per patient

时间窗: Within 6 months from the study completion

Accuracy for detection of recurrent HCC per patient

次要结局

  • Sensitivity per patient(Within 6 months from the study completion)
  • Specificity per patient(Within 6 months from the study completion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dong Ho Lee

Clinical professor

Seoul National University Hospital

研究点 (3)

Loading locations...

相似试验